Gynaecomastia: The anastrozole paradox

Journal of Pediatric Endocrinology and Metabolism

Volumn 23, Issue 1-2, 2010, Pages 205-206

  Bedognetti, Davide ^a,c   Rubagotti, Alessandra ^a,b   Zoppoli, Gabriele ^a,c   Boccardo, Francesco ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANDROGEN; BICALUTAMIDE; CONNECTIVE TISSUE GROWTH FACTOR; ESTRADIOL; GROWTH HORMONE; PLACEBO; PROLACTIN; SOMATOMEDIN C; TAMOXIFEN; TESTOSTERONE;

BREAST REDUCTION; CLINICAL TRIAL; DRUG ABSORPTION; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG INHIBITION; ECHOGRAPHY; GYNECOMASTIA; HORMONAL THERAPY; HUMAN; HYALINE DEGENERATION; LETTER; MAMMARY GLAND; MASTALGIA; PROSTATE CANCER; PUBERTY; TREATMENT OUTCOME;

EID: 77950817195     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2010.23.1-2.205     Document Type: Letter

References (9)

1. Mauras N, Bishop K, et al. Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia. J Clin Endocrinol Metab 2009; 94: 2975-2978.
2. Plourde PV, Reiter EO, et al. Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebocontrolled trial. J Clin Endocrinol Metab 2004; 89: 4428-4433.
3. Boccardo F, Rubagotti A, et al. Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. J Clin Oncol 2005; 23: 808-815. (Pubitemid 46224180)
4. Boccardo F, Rubagotti A, et al. Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients. Int J Biol Markers 2006; 21: 123-126. (Pubitemid 44210041)
5. Saltzstein D, Sieber P, et al. Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole. Prostate Cancer Prostatic Dis 2005; 8: 75-83.
6. Braunstein GD. Clinical practice. Gynecomastia. N Engl J Med 2007; 357: 1229-1237.
7. Bedognetti D, Rubagotti A, et al. An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients. Eur Urol 2010; 57: 238-245.
8. Derman O, Kanbur NO, et al. The effect of tamoxifen on sex hormone binding globulin in adolescents with pubertal gynecomastia. J Pediatr Endocrinol Metab 2004; 17: 1115-1119. (Pubitemid 39173394)
9. Lawrence SE, Faught KA, et al. Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr 2004; 145: 71-76.